Balancing POC and Lab Testing for Diabetes Management
It's essential to integrate point-of-care testing devices cautiously alongside traditional laboratory tests to ensure robust diabetes management.
It's essential to integrate point-of-care testing devices cautiously alongside traditional laboratory tests to ensure robust diabetes management.
A new study encourages the use of more reliable tests to prevent pregnancy complications and the development of type II diabetes.
A new study aimed to develop a non-invasive method for early detection of GDM using cell-free DNA (cfDNA) and deep learning models.
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, a new study found.
Read MoreAdding screening for type 2 diabetes in accident and emergency departments could uncover thousands of previously undiagnosed cases every year.
Read MoreA prototype sensor that measures glucose levels in saliva could eventually offer a simple and painless way for people to monitor diabetes.
Read MoreWhile A1c is the diagnostic gold standard for determining if a patient has diabetes, there are a variety of tests that provide flexibility.
Read MoreADLM, in collaboration with the ADA, released evidence-based guidelines to help diagnose patients with diabetes using the latest lab tools.Â
Read MoreThe U.S. FDA has granted a Breakthrough Device Designation for the Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers.
Read MoreScientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
Read MoreOmegaQuant has been awarded a grant to develop a dried blood spot test identifying fatty acid patterns that predict metabolic syndrome and type 2 diabetes as early screening tools.
Read MoreNew research from NIH found that blood glucose levels obtained at childhood examinations predicted future diabetes-related complications.
Read MoreIt’s hoped new understanding of the GCK gene and its role in the development of diabetes could help increase the usefulness of DNA sequencing.
Read MoreDigital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read MoreOrange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MoreAnalyzing changes to DNA in the blood can improve the ability to predict a person’s risk of developing type 2 diabetes within a decade.
Read MoreThe new panels are designed to target dozens of microbially-derived metabolites across multiple pathways to advance pre-clinical efforts.
Read MoreA recent study compared the gut microbiota and gut-derived metabolites between healthy controls and individuals with fatty liver.
Read More